Connor Group’s Life Sciences IPO Summit planned for June

Connor Group is set to host its annual Life Sciences IPO Summit at the Nasdaq Entrepreneurial Center in San Francisco on June 7, 2023. This conference is an essential event for Life Science companies considering an IPO and needs to navigate the current market.

The theme this year is Preparing for the Market Rebound.

Sessions are presented by executives from Life Sciences companies that have recently gone public. They will share firsthand experiences across multiple sessions - capital markets update, perspectives from venture capital and private equity firms, an IPO readiness panel, and a board composition and corporate governance discussion. Well-planned topics and presentations will showcase important details companies need to evaluate where they are in the IPO process and how to start positioning for future success.

The summit concludes with a reception where attendees can share ideas and have detailed conversations with their peers. Connor Group SMEs will be on-hand to talk more about preparing for an IPO going forward and having the empowering strength of technology behind it.

Agenda Includes:

Capital Markets Discussion – presented by: JP Morgan

Venture Capital and Private Equity Perspectives – presented by: Patient Square Capital, TPG Life Sciences Innovation and Vivo Capital

Public Company Readiness - presented by: CymaBay Therapeutics and DICE Therapeutics

Board Composition & Corporate Governance - presented by: Potrero Hill Advisors and Vir Biotechnology, Inc.

To request an invite go to: Request an invite